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a b s t r a c t
The aim of the present work is to discuss the report of a patient who had simultaneous 
diagnosis of two rare diseases, vasculitis related to antineutrophil cytoplasmic antibodies 
and chronic lymphocytic leukemia. Both are diseases that may be multisystemic and thus 
cause diagnostic confusion. In this case, the patient had renal, pulmonary, hematological, 
and ocular symptoms, which could be secondary to vasculitis both as to leukemia. With the 
aid of imaging studies, pathological studies, immunohistochemistry and immunopheno-
typing, we conclude that it was a combination of the two diseases. There are other reports 
in literature of this association, however, with pANCA positive, this is the first report of 
chronic lymphocytic leukemia associated with cANCA positive vasculitis.
© 2014 Elsevier Editora Ltda. All rights reserved.
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Vasculite associada à ANCA e leucemia linfocítica crônica: uma rara 
associação
Palavras-chave:
Vasculite Associada a Anticorpo 
Anticitoplasma de Neutrófilos
Leucemia Linfocítica Crônica de 
Células B
Granulomatose de Wegener
r e s u m o
O presente trabalho tem por objetivo uma discussão acerca do relato de um doente que 
teve o diagnóstico simultâneo de duas doenças pouco frequentes, a vasculite relaciona-
da ao anticorpo anticitoplasma de neutrófilos e a leucemia linfocítica crônica. Ambas são 
doenças que podem apresentar envolvimento multissistêmico e, assim, causar confusão 
diagnóstica. Neste caso, o doente apresentou comprometimento renal, pulmonar, hema-
tológico e ocular, que poderiam ser secundários tanto à vasculite quanto à leucemia. Com 
auxílio de exames de imagem, estudos anátomopatológicos, imuno-histoquímica e imuno-
fenotipagem concluímos tratar-se de uma associação das duas doenças. Há, na literatura, 
outros relatos desta associação, no entanto, com pANCA positivo; este é o primeiro relato 
de leucemia linfocítica crônica associada à vasculite com cANCA positivo.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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Fig. 1 – Tomography showing centrilobular pulmonary 
nodules, bronchiectasis, ground-glass opacities and pleural 
thickening.
Introduction
The group of vasculitides related to antineutrophil cytoplas-
mic antibodies (ANCA) is characterized by necrotizing inflam-
mation of small vessels. The clinical manifestations of these 
vasculitides are diverse and multisystemic. Pertain to this 
group Wegener's granulomatosis (WG), microscopic polyangi-
itis and Churg-Strauss syndrome.
Chronic lymphocytic leukemia (CLL) is a chronic lymphop-
roliferative disease; its etiology remains unclear, and is char-
acterized by clonal proliferation of B lymphocytes. Often CLL 
is associated with autoimmune phenomena, mainly related 
to cells of the hematopoietic system, especially cytopenias.
Between ANCA associated vasculitides, WG is the most 
common and its annual incidence ranges from 1.3 to 14.4 per 
1 million inhabitants.1 CLL has a higher incidence, ranging 
from 3.5 to 13.7 per 100,000 inhabitants.2
The objective of this report is to show the association 
between two rare complex diseases, CLL and ANCA-related 
vasculitis, and this is the first report of this association with 
positive cANCA.
Case report
Man, 63 years old, black, driver (retired), hypertensive. Af-
ter nine months of admission, edema, purpuric lesions and 
paresthesia in the lower limbs emerged, in association with 
malaise, weight loss (3 kg), daily fever and night sweats.
On physical examination, the patient was pale, emaciat-
ed and with lower limb edema +++/4, palpable purpura and 
decreased surface sensitivity.
Laboratory tests showed normochromic normocytic ane-
mia (Hb 11.8 g/dL), leukocytosis (25,800/μL with 48% neutro-
phils and 46% lymphocytes), hypoalbuminemia (albumin, 
3.0 mg/dL) and renal dysfunction (serum creatinine 13.4 mg/
dL and urea, 175 mg/100 mL) with 24-hour hematuria and 
proteinuria = 1.04 g.
The possibility of infection was disregarded. Radiogra-
phies and CT scan were normal. Complement consumption 
was not verified. The search for cryoglobulins and cold ag-
glutinin was negative. cANCA and anti-proteinase 3 were 
positive.
The electromyography confirmed a mixed sensory-motor 
polyneuropathy in lower limbs, with distal predominance.
The renal biopsy showed proliferative glomerulonephritis 
with diffuse endo- and extracapillary crescents. Immunoflu-
orescence was positive for IgG and C3.
The skin biopsy of the lower limb was compatible with 
leukocytoclastic vasculitis. Immunophenotyping of periph-
eral blood was performed and showed positivity for: CD5, 
CD19, CD23, CD38, CD22, CD20 (weak), CD79b (weak) and 
CD11 (weak).
Then, the diagnosis of CLL associated with ANCA vascu-
litis was confirmed.
It was decided to start pulse therapy with 1 g/day meth-
ylprednisolone × 3 days and cyclophosphamide 500 mg 
monthly. CLL had no indication for treatment, just obser-
vation. The patient developed progressive clinical improve-
ment. Six months after the onset of immunosuppression, the 
patient had a creatinine of 2.1 mg / dL.
After one year, the patient was being treated with azathio-
prine 200 mg/day in combination with prednisone 10 mg/day 
when he started presenting progressive leukopenia, intermit-
tent fever and weight loss. Azathioprine was discontinued 
and the prednisone dose was escalated to 40 mg/day with a 
satisfactory response.
After two months the patient again presented fever, weak-
ness, weight loss and, now, productive cough. Tomography 
was requested (Fig. 1), showing changes suggestive of WG: 
centrilobular pulmonary nodules, bronchiectasis, ground-
glass opacities and pleural thickening. A transbronchial biop-
sy revealed chronic nonspecific peribronchial inflammation 
without granulomas and with negative immunophenotype 
for CLL. Thus, new immunosuppression induction with meth-
ylprednisolone and cyclophosphamide was performed.
On this same occasion the patient complained of pain and 
intense ocular hyperemia with progressive decrease in visual 
acuity. On ophthalmologic examination, the patient was diag-
nosed with anterior uveitis with epithelial precipitates, which 
also improved after immunosuppression.
Discussion
This report describes the case of a patient diagnosed with two 
relatively rare diseases in combination. This is probably the 
first case in the literature of CLL associated with cANCA-posi-
tive vasculitis.
During the entire follow-up period there was difficulty in 
differentiating the clinical manifestations presented by the 
patient, whether they were secondary to vasculitis or to CLL, 
since most of them were nonspecific but compatible with both 
diseases.
Initially , the patient had severe renal dysfunction second-
ary to pauci-immune crescentic glomerulonephritis (PICGN), 
with positivity for IgG and C3. The PICGN related to CLL has 
been described in rare reports. In the literature there are nine 
cases of this association and six of them were positive for p-
ANCA.3 ANCA has a direct implication in the pathogenesis of 
PICGN, and apparently this is reproduced in patients with CLL. 
The occurrence of ANCA in patients with CLL, however, is less 
than 2%.4
In WG, there is evidence of renal involvement in up to 80 
% of patients, generally pauci-immune glomerulonephritides 
(immunohistochemistry with a higher frequency of IgM and 
C3), in which the characteristic lesion is a necrotizing glomer-
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ulonephritis with extracapillary proliferation.5 For the other 
hand, in CLL there are studies showing renal involvement in up 
to 63%, but rarely as the cause of acute renal failure. The most 
common types of glomerulonephritis associated with CLL are: 
membranoproliferative, cryoglobulinemic, membranous, with 
minimal lesions, focal and segmental glomerulosclerosis and 
amyloidosis.6
Subsequently, the patient developed neutropenia, which 
could be explained by several mechanisms. Among them, the 
use of azathioprine (but the patient did use this drug for 10 
months and had never had such a complication, autoimmune 
origin, or bone marrow failure. Individuals with CLL have a risk 
of 5-10% to develop autoimmune disease, mainly cytopenia. 
The most common is hemolytic anemia and, less frequently, 
thrombocytopenia and pure red cell aplasia.7 Rare cases mani-
fest autoimmune granulocytopenia, and it is believed that this 
complication is related to the presence of ANCA.8
After an asymptomatic period, the patient developed lung 
manifestations. The CT appearance was nonspecific, but con-
sistent with manifestations of WG, and a lung biopsy discarded 
the possibility of CLL. In individuals with WG, there is lung in-
volvement in about 80%, at some stage of the disease. These 
patients present with a wide spectrum of tomographic pat-
terns, not necessarily improve with clinical remission of dis-
ease and its confirmation is obtained by lung biopsy. The most 
common CT findings are nodules, with or without cavitation, 
and less frequency masses, bronchial wall thickening, consoli-
dation, ground-glass opacities and pleural effusion.9
The lymphoproliferative diseases represent a spectrum of 
lymphoid abnormalities that may involve the lung, from be-
nign lesions to those with potential for neoplastic transforma-
tion. In CLL, a possible lung manifestation is lymphomatoid 
granulomatosis, characterized by an angiocentric lymphoid 
infiltrate and that has great similarity with the lung manifes-
tations of WG. The patient may exhibit multisystem involve-
ment, including ocular and neurologic manifestations.10
Concomitant with the pulmonary picture, the patient 
showed ocular involvement, diagnosed as uveitis. The ophthal-
mologic manifestations occur in up to 58% of patients with WG, 
and can affect any part of the eye. Uveitis, in particular, is not a 
common manifestation of WG, but has been previously report-
ed. In some series, uveitis is the least common form of ocular 
involvement in cases of WG. The most common manifestation 
seems to be the orbital disease, followed by abnormalities of 
the sclera, episclera, cornea and nasolacrimal region.11
In CLL, the secondary involvement of ocular tissues is also 
common and can occur in 80-90% of individuals at some time 
during the illness. There is infiltration of neoplastic cells (lym-
phocytes) in ocular tissues and the diagnosis is made by im-
munohistochemical analysis.12
In the development of this case, imaging, pathologic, im-
munohistochemical and immunophenotyping studies were 
instrumental in the etiological determination of the mani-
festations presented. We conclude that these manifestations 
were secondary to vasculitis; therefore, an appropriate treat-
ment was instituted and a satisfactory response was achieved, 
which favors the hypothesis of activity of vasculitis in associa-
tion with quiescent CLL.
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